Skip to content

Effect of Different Sedation and Analgesia Strategies on Patients With Mechanical Ventilation

Effect of Different Sedation and Analgesia Strategies on Patients With Mechanical Ventilation

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05024799
Enrollment
300
Registered
2021-08-27
Start date
2022-01-31
Completion date
2024-12-31
Last updated
2021-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Insufficiency

Brief summary

Most patients in ICU are treated with a combination of analgesics and sedatives in most cases. Due to the different mechanism of different sedative and analgesic drugs, different antagonistic or synergistic effects may occur when combined with drugs, resulting in different clinical effects, especially significant effects on ventilators for patients with assisted breathing. Therefore, this study hopes to compare the effects of different sedative and analgesic drug combinations on the duration of mechanical ventilation for patients with ventilators, so as to guide the clinical adoption of a more reasonable sedative and analgesic scheme.

Interventions

The patients in this group will be administered with fentanyl and propofol

DRUGfentanyl and dexmedetomindine

The patients in this group will be administered with fentanyl and dexmedetomindine

The patients in this group will be administered with butorphanol and propofol

DRUGButorphanol and dexmedetomindine

The patients in this group will be administered with butorphanol and dexmedetomindine

Sponsors

The Affiliated Hospital of Qingdao University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults who are treated with sedation and analgesia for invasive mechanical ventilation

Exclusion criteria

* they have baseline severe cognitive impairment; were pregnant or breast-feeding; were blind, deaf ; had second-degree or third-degree heart block or bradycardia requiring intervention; had an allergy to the experimental drugs; had an indication for benzodiazepines; were anticipated to have immediate discontinuation of mechanical ventilation; were expected to have neuromuscular blockade for more than 48 hours; were in a moribund state; or had received mechanical ventilation for more than 96 hours before meeting all inclusion criteria.

Design outcomes

Primary

MeasureTime frame
ventilator-free days at 28 daysat 28 days

Contacts

Primary ContactJinyan Xing, Dr
xingjy@qdu.edu.cn86-0532-82919386

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026